Regarding the MPTP primate model, major limitations are the toxic nature of the lesion, the lack of progression and the absence of alpha-synuclein cytoplasmic inclusions [60].Therefore, the compensatory or regenerative mechanisms induced by MPTP can be radically different from those occurring in clinical Parkinson’s disease. The gene discussed is SNCA; the disease is Parkinson disease.